Jonathan Pritz

Jonathan Pritz is an experienced professional in the field of investment management, currently serving as an Analyst and Senior Associate in the TechAtlas division of RA Capital Management, L.P., a firm focused on evidence-based investing in healthcare and life sciences. Previously, Jonathan Pritz worked as a Graduate Student Researcher at Dana-Farber Cancer Institute from September 2012 to December 2017. Jonathan Pritz holds a Doctor of Philosophy (PhD) in Biological Chemistry and Molecular Pharmacology from Harvard University and a Bachelor of Science (BS) in Microbiology and Cell Science from the University of Florida.